Trials / Unknown
UnknownNCT00402519
APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast Cancer
Interstitial Brachytherapy Alone Versus External Beam Radiation Therapy After Breast Conserving Surgery for Low-risk Invasive Carcinoma and Low-risk Ductal Carcinoma in Situ (DCIS) of the Female Breast
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,300 (actual)
- Sponsor
- University of Erlangen-Nürnberg Medical School · Academic / Other
- Sex
- Female
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
To assess the role of interstitial brachytherapy alone compared to whole breast irradiation in a defined low-risk group of invasive breast cancer or ductal carcinoma in situ concerning local failure (all ipsilateral local recurrences) to affirm the hypothesis that local control rates in each arm are equivalent.
Detailed description
To assess the role of interstitial brachytherapy alone compared to whole breast irradiation in a defined low-risk group of invasive breast cancer or ductal carcinoma in situ concerning local failure (all ipsilateral local recurrences) to affirm the hypothesis that local control rates in each arm are equivalent.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Accelerated partial breast irradiation | APBI with PDR and HDR brachytherapy |
| RADIATION | External beam whole breast irradiation | Standard Whole breast irradiation |
Timeline
- Start date
- 2004-11-01
- Primary completion
- 2009-11-01
- Completion
- 2019-11-01
- First posted
- 2006-11-22
- Last updated
- 2016-05-13
Locations
11 sites across 5 countries: Austria, Germany, Hungary, Poland, Spain
Source: ClinicalTrials.gov record NCT00402519. Inclusion in this directory is not an endorsement.